Nervous mechanisms involved in experimentally induced extrapyramidal disturbances.
D000818:Animals; D001480:Basal Ganglia Diseases; D001590:Benztropine / Q000627:therapeutic use; D001921:Brain / Q000378:metabolism; D002415:Cats; D002421:Caudate Nucleus / Q000032:analysis; D002529:Cerebellar Nuclei; D002746:Chlorpromazine; D003342:Corpus Striatum / Q000378:metabolism; D004195:Disease Models, Animal; D004298:Dopamine / Q000032:analysis / Q000378:metabolism; D006220:Haloperidol; D000882:Haplorhini; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D009069:Movement Disorders / Q000139:chemically induced / Q000378:metabolism; D009847:Olivary Nucleus; D010300:Parkinson Disease / Q000209:etiology / Q000503:physiopathology; D011699:Putamen / Q000032:analysis; D051381:Rats; D012012:Red Nucleus; D013378:Substantia Nigra / Q000378:metabolism; D013787:Thalamic Nuclei; D014202:Tremor / Q000139:chemically induced / Q000188:drug therapy
D001590:Benztropine; D007980:Levodopa; D006220:Haloperidol; D002746:Chlorpromazine; D004298:Dopamine